These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 24094627)

  • 21. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer.
    Posner MC; Gooding WE; Lew JI; Rosenstein MM; Lembersky BC
    Surgery; 2001 Oct; 130(4):620-6; discussion 626-8. PubMed ID: 11602892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
    Nomura M; Shitara K; Kodaira T; Hatooka S; Mizota A; Kondoh C; Yokota T; Takahari D; Ura T; Muro K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):946-52. PubMed ID: 21362578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
    Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
    Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive radiotherapy using helical tomotherapy for head and neck cancer in definitive and postoperative settings: initial results.
    Capelle L; Mackenzie M; Field C; Parliament M; Ghosh S; Scrimger R
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):208-15. PubMed ID: 22196796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct effects of chemoradiotherapy following esophagectomy.
    Marton S; Juhasz V; Bogar L; Papp A; Cseke L; Horvath PO; Koszegi T; Ghosh S
    Eur Surg Res; 2011; 47(2):63-9. PubMed ID: 21701176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report.
    Henry LR; Goldberg M; Scott W; Konski A; Meropol NJ; Freedman G; Weiner LM; Watts P; Beard M; McLaughlin S; Cheng JD
    Ann Surg Oncol; 2006 Feb; 13(2):214-20. PubMed ID: 16418887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radiochemotherapy for esophageal cancer: which nodes should be irradiated?].
    Créhange G; Quivrin M; Vulquin N; Serre AA; Maingon P
    Cancer Radiother; 2014 Oct; 18(5-6):577-82. PubMed ID: 25201634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.
    Warner S; Chang YH; Paripati H; Ross H; Ashman J; Harold K; Day R; Stucky CC; Rule W; Jaroszewski D
    Ann Thorac Surg; 2014 Feb; 97(2):439-45. PubMed ID: 24266955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States.
    Merkow RP; Bilimoria KY; McCarter MD; Chow WB; Gordon HS; Stewart AK; Ko CY; Bentrem DJ
    Cancer; 2012 Jul; 118(13):3268-76. PubMed ID: 22006369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment outcomes after intraluminal brachytherapy following definitive chemoradiotherapy in patients with esophageal cancer.
    Sharan K; Fernandes DJ; Prakash Saxena PU; Banerjee S; Sathian B
    J Cancer Res Ther; 2014; 10(2):337-41. PubMed ID: 25022388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor response after low-dose preoperative radiotherapy combined with chemotherapy for squamous cell esophageal carcinoma.
    Kobayashi N; Nakayama H; Osaka Y; Tachibana S; Nogi S; Tajima Y; Okubo M; Mikami R; Kanesaka N; Sugahara S; Hoshino S; Tsuchida A; Tokuuye K
    Anticancer Res; 2013 Mar; 33(3):1157-61. PubMed ID: 23482796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival.
    Huang SH; Lockwood G; Brierley J; Cummings B; Kim J; Wong R; Bayley A; Ringash J
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):735-40. PubMed ID: 18164844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of advanced esophageal cancer invaded to the trachea with PCR after preoperative chemoradiotherapy, which relapsed at the time of three years and seven months after resection].
    Kawasaki H; Wajima N; Miyamoto K; Maruyama A; Takahashi K; Kubo N; Hakamada K
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2388-90. PubMed ID: 22202391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reassessment of the role of enteral tube feedings for patients with esophageal cancer.
    Starr B; Davis S; Ayala-Peacock D; Blackstock WA; Levine EA
    Am Surg; 2014 Aug; 80(8):752-8. PubMed ID: 25105392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac toxicity in the radiation treatment of esophageal cancer: an emerging concern.
    Beukema JC; Langendijk JA; Muijs CT
    Future Cardiol; 2015 Jul; 11(4):367-9. PubMed ID: 26238306
    [No Abstract]   [Full Text] [Related]  

  • 38. Pruning inaccuracies in staging of inoperable carcinoma oesophagus.
    Sharma M; Sharma A
    J Cancer Res Ther; 2015; 11(4):1045. PubMed ID: 26881683
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemoradiotherapy for esophageal cancer].
    Takahari D; Muro K
    Nihon Shokakibyo Gakkai Zasshi; 2009 Jun; 106(6):771-8. PubMed ID: 19498307
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy: Asian perspectives in the immunotherapy era.
    So TH; Lam KO
    Radiother Oncol; 2020 Jun; 147():144. PubMed ID: 32442580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.